vs
STANDARD BIOTOOLS INC.（LAB）与Legacy Education Inc.（LGCY）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Legacy Education Inc.的1.0倍（$19.6M vs $19.2M），Legacy Education Inc.净利率更高（10.6% vs -177.4%，领先188.1%），Legacy Education Inc.同比增速更快（40.7% vs -11.5%），Legacy Education Inc.自由现金流更多（$512.7K vs $-23.1M）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Legacy Education Inc.是一家专业教育培训服务商，主打财商素养、房地产投资、创业、个人财富管理相关课程，主要服务北美、欧洲及部分亚太地区的个人学习者，提供线下研讨会和线上数字化课程，帮助用户掌握实用的金融与商业技能。
LAB vs LGCY — 直观对比
营收规模更大
LAB
是对方的1.0倍
$19.2M
营收增速更快
LGCY
高出52.2%
-11.5%
净利率更高
LGCY
高出188.1%
-177.4%
自由现金流更多
LGCY
多$23.6M
$-23.1M
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $19.2M |
| 净利润 | $-34.7M | $2.0M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 13.3% |
| 净利率 | -177.4% | 10.6% |
| 营收同比 | -11.5% | 40.7% |
| 净利润同比 | -28.8% | 46.0% |
| 每股收益（稀释后） | $-0.09 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABLGCY
| Q4 25 | — | $19.2M | ||
| Q3 25 | $19.6M | $19.4M | ||
| Q2 25 | $21.8M | $18.0M | ||
| Q1 25 | $40.8M | $18.6M | ||
| Q4 24 | — | $13.6M | ||
| Q3 24 | $22.1M | $14.0M | ||
| Q2 24 | $22.5M | — | ||
| Q1 24 | $45.5M | — |
净利润LABLGCY
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-34.7M | $2.2M | ||
| Q2 25 | $-33.5M | $1.2M | ||
| Q1 25 | $-26.0M | $2.8M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | $-26.9M | $2.1M | ||
| Q2 24 | $-45.7M | — | ||
| Q1 24 | $-32.2M | — |
毛利率LABLGCY
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABLGCY
| Q4 25 | — | 13.3% | ||
| Q3 25 | -168.5% | 13.9% | ||
| Q2 25 | -118.1% | 11.1% | ||
| Q1 25 | -80.8% | 19.7% | ||
| Q4 24 | — | 12.2% | ||
| Q3 24 | -120.9% | 19.1% | ||
| Q2 24 | -134.5% | — | ||
| Q1 24 | -132.2% | — |
净利率LABLGCY
| Q4 25 | — | 10.6% | ||
| Q3 25 | -177.4% | 11.3% | ||
| Q2 25 | -153.7% | 6.8% | ||
| Q1 25 | -63.8% | 15.2% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | -122.0% | 14.9% | ||
| Q2 24 | -203.3% | — | ||
| Q1 24 | -70.6% | — |
每股收益（稀释后）LABLGCY
| Q4 25 | — | $0.15 | ||
| Q3 25 | $-0.09 | $0.16 | ||
| Q2 25 | $-0.09 | $0.07 | ||
| Q1 25 | $-0.07 | $0.21 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-0.07 | $0.21 | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $21.1M |
| 总债务越低越好 | — | $660.3K |
| 股东权益账面价值 | $399.7M | $46.1M |
| 总资产 | $539.6M | $73.1M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LABLGCY
| Q4 25 | — | $21.1M | ||
| Q3 25 | $129.4M | $20.6M | ||
| Q2 25 | $158.6M | $20.3M | ||
| Q1 25 | $150.9M | $17.3M | ||
| Q4 24 | — | $16.9M | ||
| Q3 24 | $210.6M | $21.5M | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
总债务LABLGCY
| Q4 25 | — | $660.3K | ||
| Q3 25 | — | $776.9K | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $55.2M | $758.2K | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABLGCY
| Q4 25 | — | $46.1M | ||
| Q3 25 | $399.7M | $43.7M | ||
| Q2 25 | $424.5M | $41.0M | ||
| Q1 25 | $454.6M | $39.3M | ||
| Q4 24 | — | $36.4M | ||
| Q3 24 | $489.3M | $32.6M | ||
| Q2 24 | $510.3M | — | ||
| Q1 24 | $577.3M | — |
总资产LABLGCY
| Q4 25 | — | $73.1M | ||
| Q3 25 | $539.6M | $72.1M | ||
| Q2 25 | $557.0M | $69.2M | ||
| Q1 25 | $579.6M | $67.1M | ||
| Q4 24 | — | $62.1M | ||
| Q3 24 | $681.5M | $50.6M | ||
| Q2 24 | $708.7M | — | ||
| Q1 24 | $777.7M | — |
负债/权益比LABLGCY
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | 0.11× | 0.02× | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $1.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $512.7K |
| 自由现金流率自由现金流/营收 | -118.1% | 2.7% |
| 资本支出强度资本支出/营收 | 4.5% | 2.8% |
| 现金转化率经营现金流/净利润 | — | 0.52× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $4.8M |
8季度趋势，按日历期对齐
经营现金流LABLGCY
| Q4 25 | — | $1.1M | ||
| Q3 25 | $-22.2M | $1.1M | ||
| Q2 25 | $-20.7M | $3.0M | ||
| Q1 25 | $-30.3M | $918.7K | ||
| Q4 24 | — | $659.0K | ||
| Q3 24 | $-27.9M | $3.2M | ||
| Q2 24 | $-39.0M | — | ||
| Q1 24 | $-62.5M | — |
自由现金流LABLGCY
| Q4 25 | — | $512.7K | ||
| Q3 25 | $-23.1M | $809.7K | ||
| Q2 25 | $-22.6M | $2.9M | ||
| Q1 25 | $-35.3M | $596.6K | ||
| Q4 24 | — | $466.8K | ||
| Q3 24 | $-30.1M | $2.9M | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABLGCY
| Q4 25 | — | 2.7% | ||
| Q3 25 | -118.1% | 4.2% | ||
| Q2 25 | -103.6% | 16.2% | ||
| Q1 25 | -86.6% | 3.2% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | -136.4% | 21.1% | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度LABLGCY
| Q4 25 | — | 2.8% | ||
| Q3 25 | 4.5% | 1.3% | ||
| Q2 25 | 8.7% | 0.5% | ||
| Q1 25 | 12.4% | 1.7% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | 10.2% | 1.7% | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率LABLGCY
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 2.45× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
LGCY
暂无分部数据
